Luxempart S.a. · LUXSE:LXMPR
Luxempart — Shareholder Meeting (April 2026)
30 slides from Luxempart's shareholder meeting presentation, Apr 27, 2026
Slide 1: Annual General Meeting of Luxempart
ANNUAL GENERAL MEETING OF LUXEMPART 27 April 2026
Slide 2: Opening of the general meeting
Opening of the general meeting ▪ Appointment of the secretary of the meeting by the President of the General Meeting ▪ Appointment of the scrutineer by the General Meeting ▪ Acknowledgement by the General Meeting of the following declarations by the Chairman of the General Meeting: • Meeting conveni
Slide 3: Agenda of the meeting
Agenda of the meeting 1. Presentation of the main events during the financial year 2025 and of the outlook 2. Presentation of the financial results for the year 2025 3. Presentation of the management report for the financial year 2025 4. Presentation of the audit reports 5. Report on any conflict of
Slide 4: Agenda of the meeting
Agenda of the meeting 10. Discharge of the directors for the performance of their duties during the financial year 2025 11. Renewal of the mandate of Mr. Xavier Coirbay as a director for a 3-year period 12. Renewal of the mandate of Mr. Frank Donck as a director for a 3-year period 10.Discharge 13.
Slide 5: Activity report: Direct Investments & Investment Funds
1. Activity report Lower mid-cap buyout investor across two complementary activities, with strong Luxembourg roots Direct Investments (2/3) & Investment Funds (1/3) Focus: software, healthcare, industrials, financial & B2B services € 2.5BN* € 212M c. 15% +10% p.a EQUITY CASH & EQUIVALENTS IRR SINCE
Slide 6: Positive NAV growth in 2025 driven by portfolio performance
1. Activity report Positive NAV growth in 2025 driven by portfolio performance +11.3% Global NAV performance in 2025 €2,526m NAV as at 31/12/2025 €400m+ Available liquidity* 6 Annual general meeting of luxempart - 27 April 2026 *The Group’s available liquidity mainly consists of cash, liquid bond po
Slide 7: Sustainability at Luxempart
1. Activity report Sustainability at Luxempart - supporting long-term value through responsible investing Responsible investing remains a core part of Luxempart’s approach, with further structuring in 2025: AS A COMPANY AS AN INVESTOR ▪ Governance & risk management ▪ Focus on key areas: governance,
Slide 8: Direct Investments: positive performance
1. Activity report Direct Investments: positive performance driven by favourable environments in insurance and in our listed portfolio 14.3% Performance €1,663m NAV as at 31/12/2025 27 Direct portfolio lines 8 Annual general meeting of luxempart - 27 April 2026 Strictly private and confidential
Slide 9: Continued deployment alongside active portfolio rotation
1. Activity report Continued deployment alongside active portfolio rotation €92m €141m Invested Proceeds Valeara: signing of a new controlling investment (EUR 78m) in a German Engineering Services Platform: launch of a IHS Towers: exit of non-strategic position in outpatient healthcare provider. Clo
Slide 10: Investment Funds: 12.2% underlying performance
1. Activity report Investment Funds: 12.2% underlying performance, with FX impacting reported returns +9.9% +12.2% Performance Performance adjusted for FX FX impact : € -13.3m €639m NAV as at 31/12/2025 50+ Funds USD depreciation reduced reported performance in 2025, while creating more favorable fu
Slide 11: New manager relationships in 2025, focus on software managers
1. Activity report 9 new manager relationships in 2025, with a focus on software managers NAV exposure to software remains limited, while commitments were increased in 2025 to capture the next generation of value creation. €138m €74m €81m New commitments Capital called Proceeds Selected software man
Slide 12: Solid long-term performance not fully reflected in share price
1. Activity report Solid long-term performance not fully reflected in share price Strong short-term market performance sets a high comparison base, ~50% discount vs ~34% historical average (20 years) while NAV returns remain solid over the long term. 12 Annual general meeting of luxempart - 27 April
Slide 13: Positioned for continued deployment in an uncertain environment
1. Activity report Positioned for continued deployment in an uncertain environment Escalating tensions in the Middle East are driving energy price volatility and increasing inflationary pressures, with uncertain effects on our portfolio, though their extent and duration remain uncertain. We remain d
Slide 14: Presentation of the financial results for the year 2025
2. Presentation of the financial results for the year 2025 IFRS Consolidated financial statements CONSOLIDATED ACCOUNTS (in EUR million) 31/12/2025 31/12/2024 Consolidated net result 260.9 30.5 >100% Total equity 2,525.6 2,310.7 9.3% Total balance sheet 2,533.5 2,322.7 9.1% Equity - Group share (E
Slide 15: Presentation of the management report for the financial year 2025
3. Presentation of the management report for the financial year 2025 A presentation is given during the General Meeting. 15 Annual general meeting of luxempart - 27 April 2026 Strictly private and confidential
Slide 16: Presentation of the audit reports
4. Presentation of the audit reports A presentation of the audit reports relating to the consolidated financial statements and the statutory annual accounts of LUXEMPART for the financial year 2025 is given at the General Meeting. The full report on the audit of the consolidated financial statements
Slide 17: Report on any conflict of interest of a financial nature
5. Report on any conflict of interest of a financial nature The secretary general reports on any transactions decided by the Board of Directors or the Group Executive Committee in 2025 in which a director or a member of the executive committee had a financial interest opposite to that of LUXEMPART.
Slide 18: Question time
Question time Written questions: - Performance of the 2021 and 2022 vintages in our Investment Funds activity, including potential valuation gaps in the current exit environment - Investment pace in the Investment funds activity in light of recent distribution levels , and rationale for maintaining
Slide 19: Approval of the consolidated financial statements
6. Approval of the consolidated financial statements for the financial year 2025 Proposed resolution: Approval of the consolidated financial statements of LUXEMPART for the financial year 2025. 19 Annual general meeting of luxempart - 27 April 2026 Strictly private and confidential
Slide 20: Approval of the statutory annual accounts
7. Approval of the statutory annual accounts for the financial year 2025 Proposed resolution: Approval of the statutory annual accounts of LUXEMPART for the financial year 2025. LUXGAAP ACCOUNTS (in EUR million) 31/12/2025 31/12/2024 Profit / loss 66.9 24.2 >100% Total equity 1,230.0 1,210.1 1.6%
Slide 21: Allocation of the result including the declaration of a dividend
8. Allocation of the result of the financial year 2025 including the declaration of a dividend Proposed resolution: • Approval of a 2.56 EUR/share gross dividend payment (+10%) • No dividend payable on treasury shares • Approval of the allocation of the result for the financial year 2025 as below: A
Slide 22: Remuneration report of directors and executive committee
9. Presentation of the remuneration of the directors and executive committee members in 2025 and consultative vote on the 2025 remuneration report Proposed resolution: Approval by way of consultative vote of the annual report on the remuneration of the directors (including the managing directors) an
Slide 23: Discharge of the directors
10. Discharge of the directors for the performance of their duties during the financial year 2025 Proposed resolution: Grant of discharge to the directors of LUXEMPART for the exercise of their mandate during the financial year 2025. 23 Annual general meeting of luxempart - 27 April 2026 Strictly pr
Slide 24: Renewal of the mandate of the Directors
11./12./13./14./15. Renewal of the mandate of the Directors Proposed resolutions: Renewal of the mandate of the following Directors as follows: 3 yea rs 3 yea rs 1 year 3 years 3 years L* Gregoire Chertok is the permanent representative of LIDA S.A.S., Director of the Company. 24 Annual general meet
Slide 25: Appointment of Mrs. Andrea Davis as a director
16. Appointment of Mrs. Andrea Davis as a director for a period of 3 years Proposed resolution: Appointment of Mrs. Andrea Davis as a director of LUXEMPART for a term of 3 years ending on the date of the annual general meeting to be held in 2029. Mrs. Davis will bring to the Board significant execut
Slide 26: Revised executive remuneration policy and consultative vote
17. Presentation of the revised executive remuneration policy and consultative vote Proposed resolution: Approval by way of consultative vote of the revised remuneration policy for the members of management. The main changes to the Group’s remuneration policy are: ➢ Bonus: Transition from the Perfor
Slide 27: Approval of the remuneration of the directors
18. Approval of the remuneration of the directors Proposed resolution: Approval of the remuneration of the members of the Board of Directors as follows: 27 Annual general meeting of luxempart - 27 April 2026 Strictly private and confidential
Slide 28: Renewal of the mandate of the independent auditor
19. Renewal of the mandate of the independent auditor for the financial year 2026 Proposed resolution: Renewal of the mandate of KPMG Audit S.à.r.l. as independent auditor of LUXEMPART (Réviseur d’Entreprises Agréé) for the financial year 2026. 28 Annual general meeting of luxempart - 27 April 2026
Slide 29: Miscellaneous & questions
20. Miscellaneous & questions 29 Annual general meeting of luxempart - 27 April 2026 Strictly private and confidential
Slide 30: Thanks for your attention
Thanks for your attention